PsiloTech Pharma Information

PsiloTech Pharma is a pharmaceutical biotechnology company based in Jamaica, dedicated to advancing the development and global supply of pharmaceutical-grade psilocybin for approved medical and scientific research. Founded on the principles of scientific excellence, innovation and regulatory integrity, we are building a vertically integrated platform spanning cultivation, extraction, formulation and international distribution. Our focus is to provide researchers, biotechnology companies, pharmaceutical organisations and healthcare institutions with reliable, high-quality psilocybin materials that meet the standards required for clinical and investigational use. Operating within Jamaica's established regulatory framework, PsiloTech Pharma combines advanced cultivation practices with pharmaceutical manufacturing expertise and strategic global partnerships to support the next generation of evidence-based therapies. Our expertise includes pharmaceutical cultivation, extraction, formulation development, clinical trial supply, regulatory compliance, international export and strategic research collaborations. By maintaining rigorous quality assurance and traceability throughout our operations, we aim to deliver consistent, pharmaceutical-grade products that support research programmes worldwide. As interest in psychedelic-assisted therapies continues to grow, PsiloTech Pharma is committed to helping accelerate scientific discovery by providing trusted pharmaceutical solutions that enable innovation while meeting the highest regulatory and quality standards. Our vision is to become a leading international pharmaceutical biotechnology company and a trusted global supplier of pharmaceutical-grade psilocybin, supporting researchers, healthcare organisations and industry partners in developing the next generation of evidence-based medicines that have the potential to improve patient outcomes around the world.